Evidence map›Paper›PMID 41180318›Full record

ArticleHealth science reports2025

Risk Factor Analysis of Death in Patients With Hepatic Cellular Carcinoma After Radical Operation: A Consecutive Cohort of 433 Patients.

Zhengyang He, Wenfeng Lu, Dongze Qiu, Weimin She

Abstract read
In one paragraph

Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhengyang HeDepartment of Integrative Medicine Shanghai Geriatrics Medical Center Shanghai China.
Wenfeng LuDepartment of Integrative Medicine Shanghai Geriatrics Medical Center Shanghai China.
Dongze QiuDepartment of Integrative Medicine, Zhongshan Hospital Fudan University Shanghai China.
Weimin SheDepartment of Gastroenterology, Zhongshan Hospital Fudan University Shanghai China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: No matter what kind of radical operation, the recurrence and metastasis of tumor will seriously affect the postoperative long-term effect, and hinder the survival of hepatic cellular carcinoma (HCC) patients. This study aims to explore the relevant risk factors through multivariable analysis, to provide basis for the screening of prognostic factors of HCC and the prevention of tumor related events. Methods: 433 patients with HCC after radical operation were involved in this study. The general clinical data, pathological data and laboratory indicators of patients were analyzed through univariate and multivariable analysis. Finally, the independent risk factors of disease free survival (DFS) and overall survival (OS) in patients were screened out. Results: The 1-, 3-, and 5-year DFS rates were 70.67%, 49.65% and 40.65%, while the 1-, 3-, and 5-year OS rates were 90.30%, 79.68% and 70.67%, respectively. Multivariable analysis showed that tumor number, microvascular invasion, thickness of resection margin, AFP, AST and GGT were the independent risk factors of DFS, while PS score, tumor number, maximal tumor size, ES classification, microvascular invasion, AST and GGT were the independent risk factors of OS ( Conclusion: Tumor number, microvascular invasion, AST and GGT are correlated with both shorter DFS and OS, which means they can be considered as predictors of the prognosis and recurrence in patients with HCC after radical operation. Patients with these risk factors should be screened in time, which is of great significance to prevent tumor related events and improve survival.

Indexed as

cohort studyhepatic cellular carcinomaradical operationrisk factorssurvival

Identifiers

PMID41180318
PMCPMC12572618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.